SPRO Spero Therapeutics, Inc. - Common Stock
$1.21
가격 · 8월 24, 2026
기준 재무 정보 8월 12, 2026
52주 범위
$1–$3
6% of range
애널리스트 평점
HOLD
6 analysts
목표 주가
$4
+232% upside
P/E (TTM)
8.0
ROE
18.7%
순이익률
12.8%
SPRO 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$1.21
시가총액
$68M
P/E (TTM)
8.0
EPS (TTM)
$0.15
매출 (TTM)
$67M
배당 수익률
—
ROE
18.7%
부채/자본
—
52주 범위
$1 – $3
SPRO 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$67M
2016-12-31
→
2025-12-31
EPS
$0.15
2021-12-31
→
2025-12-31
잉여현금흐름
—
2017-12-31
→
2019-12-31
마진
12.8%
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
SPRO
동종업계 중앙값
P/E (TTM)
8.0
4.7
P/S (TTM)
1.0
31.0
P/B
1.2
1.8
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
SPRO
동종업계 중앙값
Operating Margin (영업이익률)
9.4%
—
Net Profit Margin (순이익률)
12.8%
-1601.1%
ROA
9.6%
-68.1%
ROE
18.7%
-111.7%
ROIC
10.4%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
SPRO
동종업계 중앙값
Current Ratio (유동비율)
7.6
4.1
Quick Ratio (당좌 비율)
4.5
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
SPRO
동종업계 중앙값
Revenue YoY (매출 YoY)
39.2%
—
Revenue CAGR 3Y (매출 CAGR 3년)
7.7%
—
Revenue CAGR 5Y (매출 CAGR 5년)
48.2%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
SPRO
동종업계 중앙값
SPRO 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매도
6 명의 애널리스트
- 적극 매수 0 0.0%
- 매수 0 0.0%
- 보유 3 50.0%
- 매도 1 16.7%
- 적극 매도 2 33.3%
12개월 목표 주가
1 명의 애널리스트 · 2026-08-23
저가
$4.00
고가
$4.00
중앙값 목표
$4.00
+232.0%
평균 목표
$4.00
+232.0%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.22%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.16 | $-0.17 | 0.01% |
| 2026년 3월 31일 | $-0.13 | $-0.18 | 0.05% |
| 2025년 12월 31일 | $0.53 | $-0.20 | 0.73% |
| 2025년 9월 30일 | $-0.13 | $-0.26 | 0.12% |
| 2025년 6월 30일 | $-0.03 | $-0.39 | 0.36% |
| 2025년 3월 31일 | $-0.25 | $-0.56 | 0.31% |
| 2024년 12월 31일 | $-0.38 | $-0.32 | -0.06% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | — |
| GOSS | $724M | -4.1 | -57.7% | -351.5% | 201.8% | — |
| FRMM | — | — | — | -6881.3% | -368.1% | — |
| ANVS | $94M | -2.5 | — | — | -164.0% | — |
| IBIO | $15M | -0.4 | 77.8% | -4594.2% | -101.5% | — |
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | — |
| RNTX | — | -0.6 | — | — | — | — |
| NMAD | — | — | — | — | — | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
| CTOR | $170M | -6.0 | — | — | -61.5% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 15
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $67M | $48M | $104M | $54M | $18M | $9M | $18M | $4M | $2M | $335.0K | |
| R&D Expense | $38M | $97M | $51M | $48M | $65M | $67M | $66M | $34M | $33M | $26M | |
| SG&A Expense | $21M | $24M | $26M | $36M | $42M | $21M | $16M | $13M | $11M | $7M | |
| Operating Expenses | $60M | $121M | $82M | $96M | $106M | $88M | $81M | $47M | $44M | $34M | |
| Operating Income | $6M | $-73M | $21M | $-42M | $-88M | $-79M | $-63M | $-43M | $-42M | $-33M | |
| Interest Income | $3M | $5M | $4M | $1M | $346.0K | $401.0K | $1M | $1M | · | · | |
| Other Non-op | $7.0K | $60.0K | $-14.0K | $-55.0K | $-395.0K | $432.0K | $740.0K | $43.0K | $2M | $580.0K | |
| Pretax Income | $9M | $-69M | $25M | $-46M | $-90M | $-78M | $-61M | $-42M | $-40M | $-33M | |
| Income Tax | $261.0K | $0 | $3M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $9M | $-69M | $23M | $-46M | $-90M | $-78M | $-61M | $-42M | $-39M | $-25M | |
| EPS (Basic) | $0.15 | $-1.27 | $0.43 | $-1.23 | $-2.91 | · | · | · | · | · | |
| EPS (Diluted) | $0.15 | $-1.27 | $0.43 | $-1.23 | $-2.91 | · | · | · | · | · | |
| Shares (Basic) | 56,020,363 | 54,037,917 | 52,703,467 | 37,585,075 | 30,895,756 | · | · | · | · | · | |
| Shares (Diluted) | 59,039,225 | 54,037,917 | 52,989,030 | 37,585,075 | 30,895,756 | · | · | · | · | · | |
| EBITDA | $6M | $-73M | $22M | $-41M | $-87M | · | $-62M | $-42M | $-41M | · |
대차대조표 21
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $40M | $53M | $76M | $109M | $113M | $85M | $30M | $34M | $87M | $10M | |
| Short-term Investments | · | · | · | $0 | $34M | $42M | $52M | $81M | · | · | |
| Prepaid Expense | $2M | $2M | $4M | $3M | $9M | $6M | $5M | $7M | $2M | $1M | |
| Other Current Assets | $28.0K | · | · | · | · | · | · | · | · | · | |
| Current Assets | $67M | $107M | $131M | $114M | $158M | $139M | $95M | $124M | $92M | $12M | |
| PP&E (Net) | · | $0 | $2.0K | $368.0K | $1M | $2M | $2M | $3M | $1M | $2M | |
| PP&E (Gross) | · | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $2M | $2M | |
| Accum. Depreciation | · | $4M | $4M | $3M | $3M | $2M | $2M | $827.0K | $643.0K | $290.0K | |
| Other Non-current Assets | $153.0K | $153.0K | $435.0K | $6M | $6M | $5M | $4M | $2M | · | · | |
| Total Assets | $69M | $111M | $182M | $125M | $171M | $153M | $106M | $129M | $93M | $14M | |
| Accounts Payable | $693.0K | $7M | $1M | $617.0K | $1M | $1M | $4M | $4M | $3M | $1M | |
| Current Liabilities | $9M | $49M | $37M | $22M | $19M | $14M | $27M | $12M | $8M | $7M | |
| Capital Leases | $939.0K | $3M | $4M | $5M | $6M | $7M | $5M | · | · | · | |
| Total Liabilities | $10M | $64M | $75M | $49M | $83M | $21M | $32M | $13M | $9M | $7M | |
| Common Stock | $56.0K | $55.0K | $53.0K | $52.0K | $32.0K | $29.0K | $19.0K | $17.0K | $14.0K | $0 | |
| Paid-in Capital | · | · | · | · | · | · | · | $254M | $181M | $0 | |
| Retained Earnings | $-451M | $-460M | $-391M | $-414M | $-367M | $-278M | $-199M | $-139M | $-97M | $-45M | |
| AOCI | · | · | $0 | $0 | $-2.0K | $-7.0K | $16.0K | $-28.0K | · | · | |
| Stockholders' Equity | $59M | $46M | $107M | $76M | $88M | $132M | $75M | $116M | $85M | $-45M | |
| Liabilities + Equity | $69M | $111M | $182M | $125M | $171M | $153M | $106M | $129M | $93M | $14M | |
| Shares Outstanding | 56,414,657 | 54,593,527 | 52,999,680 | 52,456,195 | 32,393,738 | 29,260,247 | 19,190,695 | 17,205,962 | 14,369,182 | 0 |
현금 흐름 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $0 | $2.0K | $367.0K | $869.0K | $646.0K | $761.0K | $750.0K | $409.0K | $363.0K | $279.0K | |
| Stock-based Comp | $4M | $8M | $8M | $9M | $9M | $5M | $4M | $3M | $1M | $180.0K | |
| Deferred Tax | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Restructuring | $258.0K | $877.0K | $0 | $12M | $0 | · | · | · | · | · | |
| Other Non-cash | $-26M | $37M | $-64M | $29M | $15M | · | $6M | $-1M | $-2M | · | |
| Operating Cash Flow | $-13M | $-23M | $-33M | $-8M | $-64M | $-86M | $-50M | $-40M | $-39M | $-29M | |
| CapEx | · | · | · | · | · | $157.0K | $314.0K | $2M | $27.0K | $830.0K | |
| Investing Cash Flow | · | · | $0 | $34M | $8M | $10M | $30M | $-83M | $-27.0K | $-830.0K | |
| Stock Issued | · | $0 | $221.0K | · | $8M | $13M | $16M | · | · | · | |
| Net Stock Activity | · | $0 | · | · | $8M | · | $16M | · | · | · | |
| Financing Cash Flow | · | $0 | $221.0K | $-30M | $84M | $131M | $16M | $70M | $116M | $34M | |
| Net Change in Cash | $-13M | $-23M | $-33M | $-3M | $27M | $55M | $-4M | $-53M | $77M | $5M | |
| Free Cash Flow | · | · | · | · | · | · | $-50M | $-42M | $-39M | · |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 9.4% | -152.9% | 20.7% | -78.9% | -481.9% | · | -348.4% | -1079.3% | · | · | |
| Net Margin | 12.8% | -142.9% | 22.0% | -86.7% | -491.9% | · | -335.6% | -1050.5% | · | · | |
| Pretax Margin | 13.2% | -142.9% | 24.5% | -86.7% | -491.7% | · | -335.7% | -1050.5% | · | · | |
| EBITDA Margin | 9.4% | -152.9% | 21.1% | -77.2% | -478.3% | · | -344.2% | -1069.0% | · | · | |
| ROA | 9.6% | -46.8% | 14.8% | -31.4% | -55.3% | · | -51.8% | -37.5% | -72.2% | · | |
| ROE | 18.7% | -122.8% | 28.4% | -85.6% | -89.7% | · | -64.1% | -41.6% | -197.9% | · | |
| ROIC | 10.4% | -159.1% | 18.0% | -55.6% | -99.6% | · | -84.8% | -37.1% | -49.3% | · |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.6 | 2.2 | 3.5 | 5.2 | 8.5 | · | 3.6 | 10.1 | 11.3 | · | |
| Quick Ratio | 4.5 | 1.1 | 2.1 | 5.0 | 7.8 | · | 3.1 | 9.4 | 10.7 | · |
효율성 1
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.3 | 0.7 | 0.4 | 0.1 | · | 0.2 | 0.0 | · | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 39.2% | -53.8% | 94.0% | 193.1% | 95.7% | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.7% | 38.0% | 123.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 48.2% | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $67M | $48M | $104M | $54M | $18M | $9M | $18M | $4M | $2M | · | |
| Net Income TTM | $9M | $-69M | $23M | $-46M | $-90M | $-78M | $-61M | $-42M | $-39M | · | |
| Market Cap | $131M | $56M | $78M | $91M | $519M | · | $185M | $106M | $169M | · | |
| P/E | 15.5 | -0.8 | 3.4 | -1.4 | -5.5 | · | · | · | · | · | |
| P/S | 2.0 | 1.2 | 0.8 | 1.7 | 28.4 | · | 10.2 | 26.7 | 85.3 | · | |
| P/B | 2.2 | 1.2 | 0.7 | 1.2 | 5.9 | · | 2.5 | 0.9 | 2.0 | · | |
| P / Tangible Book | 2.2 | 1.2 | 0.7 | 1.2 | 5.9 | 4.3 | · | · | · | · | |
| P / Cash Flow | -10.4 | -2.4 | -2.4 | -11.7 | -8.1 | · | -3.7 | -2.7 | -4.3 | · | |
| P / FCF | · | · | · | · | · | · | -3.7 | -2.5 | -4.3 | · | |
| Earnings Yield | 6.4% | -123.3% | 29.2% | -71.1% | -18.2% | · | · | · | · | · |
손익계산서 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $258.0K | $41M | $5M | $14M | $6M | $15M | $13M | $10M | $9M | $74M | $25M | $3M | $2M | $47M | $2M | |
| R&D Expense | $3M | $3M | $6M | $9M | $11M | $14M | $29M | $27M | $24M | $17M | $17M | $16M | $10M | $9M | $15M | $7M | |
| SG&A Expense | $6M | $5M | $4M | $4M | $6M | $7M | $7M | $5M | $6M | $6M | $6M | $6M | $6M | $7M | $6M | $7M | |
| Operating Expenses | $10M | $8M | $10M | $13M | $17M | $21M | $37M | $32M | $29M | $23M | $23M | $27M | $16M | $16M | $22M | $14M | |
| Operating Income | $-10M | $-8M | $31M | $-8M | $-2M | $-15M | $-22M | $-19M | $-19M | $-14M | $51M | $-2M | $-13M | $-14M | $26M | $-12M | |
| Interest Income | $377.0K | $336.0K | $376.0K | $532.0K | $740.0K | $864.0K | $1M | $1M | $1M | $1M | $1M | $950.0K | $982.0K | $963.0K | $715.0K | $208.0K | |
| Other Non-op | $-3.0K | $-1.0K | $0 | $2.0K | $4.0K | $1.0K | $99.0K | $-26.0K | $1.0K | $-14.0K | $4.0K | $-10.0K | $-6.0K | $-2.0K | $-9.0K | $-23.0K | |
| Income Tax | · | · | $261.0K | $0 | · | · | $-290.0K | $290.0K | · | · | $387.0K | $2M | · | · | $0 | $0 | |
| Net Income | $-10M | $-7M | $32M | $-7M | $-2M | $-14M | $-21M | $-17M | $-18M | $-13M | $51M | $-3M | $-12M | $-13M | $27M | $-12M | |
| EPS (Basic) | $-0.16 | $-0.13 | $0.56 | $-0.13 | $-0.03 | $-0.25 | $-0.38 | $-0.32 | $-0.33 | $-0.24 | $0.97 | $-0.06 | $-0.23 | $-0.25 | $0.98 | $-0.33 | |
| EPS (Diluted) | $-0.16 | $-0.13 | $0.56 | $-0.13 | $-0.03 | $-0.25 | $-0.38 | $-0.32 | $-0.33 | $-0.24 | $0.97 | $-0.06 | $-0.23 | $-0.25 | $0.98 | $-0.33 | |
| Shares (Basic) | 57,968,608 | 57,281,570 | -111,663,436 | 56,280,844 | 56,026,767 | 55,376,188 | -107,568,748 | 54,124,862 | 53,957,766 | 53,524,037 | -105,105,644 | 52,710,280 | 52,571,813 | 52,527,018 | -63,881,523 | 35,882,076 | |
| Shares (Diluted) | 57,968,608 | 57,281,570 | -108,644,574 | 56,280,844 | 56,026,767 | 55,376,188 | -107,568,748 | 54,124,862 | 53,957,766 | 53,524,037 | -104,820,081 | 52,710,280 | 52,571,813 | 52,527,018 | -63,881,523 | 35,882,076 | |
| EBITDA | $-10M | $-8M | · | $-8M | $-2M | $-15M | · | $-19M | $-19M | $-14M | · | $-2M | $-13M | $-14M | · | $-12M |
대차대조표 20
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $56M | $40M | $49M | $31M | $49M | $53M | $76M | $64M | $82M | $76M | $94M | $78M | $96M | $109M | $50M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Prepaid Expense | $785.0K | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $3M | $4M | $4M | $5M | $9M | $4M | $3M | $1M | |
| Other Current Assets | $25.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $52M | $58M | $67M | $52M | $59M | $75M | $107M | $132M | $122M | $140M | $131M | $102M | $88M | $102M | $114M | $53M | |
| PP&E (Net) | · | · | · | · | · | · | · | $0 | $0 | $2.0K | $2.0K | $41.0K | $148.0K | $256.0K | $368.0K | $494.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | $4M | · | · | · | $4M | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | $4M | · | · | · | $3M | · | |
| Other Non-current Assets | $153.0K | $153.0K | $153.0K | $153.0K | $153.0K | $153.0K | $153.0K | $153.0K | $434.0K | $434.0K | $435.0K | $434.0K | $6M | $6M | $6M | $6M | |
| Total Assets | $53M | $59M | $69M | $54M | $62M | $78M | $111M | $135M | $150M | $168M | $182M | $107M | $99M | $113M | $125M | $64M | |
| Accounts Payable | $155.0K | $217.0K | $693.0K | $1M | $780.0K | $2M | $7M | $6M | $3M | $3M | $1M | $1M | $1M | $583.0K | $617.0K | $3M | |
| Current Liabilities | $8M | $5M | $9M | $14M | $15M | $29M | $49M | $49M | $46M | $42M | $37M | $25M | $17M | $23M | $22M | $16M | |
| Capital Leases | $43.0K | $507.0K | $939.0K | $1M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | |
| Total Liabilities | $9M | $6M | $10M | $28M | $29M | $44M | $64M | $70M | $69M | $71M | $75M | $53M | $44M | $48M | $49M | $32M | |
| Common Stock | $58.0K | $58.0K | $56.0K | $56.0K | $56.0K | $56.0K | $55.0K | $54.0K | $54.0K | $54.0K | $53.0K | $53.0K | $53.0K | $53.0K | $52.0K | $43.0K | |
| Retained Earnings | $-468M | $-458M | $-451M | $-483M | $-475M | $-474M | $-460M | $-439M | $-422M | $-404M | $-391M | $-442M | $-439M | $-427M | $-414M | $-441M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Stockholders' Equity | $44M | $53M | $59M | $26M | $33M | $34M | $46M | $66M | $80M | $96M | $107M | $54M | $55M | $65M | $76M | $32M | |
| Liabilities + Equity | $53M | $59M | $69M | $54M | $62M | $78M | $111M | $135M | $150M | $168M | $182M | $107M | $99M | $113M | $125M | $64M | |
| Shares Outstanding | 58,146,910 | 57,891,493 | 56,414,657 | 56,311,795 | 56,187,308 | 55,900,641 | 54,593,527 | 54,314,415 | 54,009,139 | 53,869,139 | 52,999,680 | 52,999,317 | 52,571,813 | 52,571,813 | 52,456,195 | 42,856,623 |
현금 흐름 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $0 | $0 | · | · | $0 | $0 | $2.0K | $0 | $38.0K | $108.0K | $108.0K | $113.0K | $129.0K | $257.0K | |
| Stock-based Comp | $822.0K | $1M | $1M | $1M | $714.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | $0 | $0 | $0 | $0 | $83.0K | $175.0K | $877.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-67.0K | $-152.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $17M | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-5M | $16M | $-8M | $17M | $-18M | $-4M | $-23M | $13M | $-19M | $6M | $-17M | $16M | $-19M | $-13M | $44M | $-957.0K | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-129.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $1.0K | $220.0K | $0 | $0 | · | $6M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | · | · | · | · | · | · | · | · | · | · | $1.0K | $220.0K | $0 | $0 | $14M | $6M | |
| Net Change in Cash | $-5M | $16M | $-8M | $17M | $-18M | $-4M | $-23M | $13M | $-19M | $6M | $-17M | $16M | $-19M | $-13M | $59M | $5M |
수익성 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -2921.7% | · | -145.5% | -17.2% | -250.8% | · | -138.0% | -186.9% | -150.9% | · | -7.6% | -474.6% | -687.6% | · | -589.9% | |
| Net Margin | · | -2791.9% | · | -135.7% | -12.0% | -236.1% | · | -127.3% | -175.5% | -137.1% | · | -12.6% | -438.1% | -642.8% | · | -583.2% | |
| EBITDA Margin | · | -2921.7% | · | -145.5% | -17.2% | -250.8% | · | -138.0% | -186.9% | -150.9% | · | -7.6% | -474.6% | -682.2% | · | -589.9% | |
| ROA | -16.6% | -10.5% | · | -7.8% | -1.6% | -11.3% | · | -14.2% | -14.4% | -9.1% | · | -3.7% | -14.6% | -10.3% | · | -11.2% | |
| ROE | -24.8% | -16.6% | · | -16.1% | -3.0% | -21.3% | · | -28.8% | -26.5% | -15.8% | · | -7.4% | -26.2% | -20.9% | · | -16.2% |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 10.5 | · | 3.8 | 4.0 | 2.6 | · | 2.7 | 2.7 | 3.4 | · | 4.0 | 5.1 | 4.4 | · | 3.3 | |
| Quick Ratio | 6.0 | 10.2 | · | 3.6 | 2.1 | 1.7 | · | 1.6 | 1.4 | 2.0 | · | 3.7 | 4.5 | 4.2 | · | 3.1 |
효율성 1
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.3 | 0.0 | 0.0 | · | 0.0 |
가치 평가 (TTM) 9
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $26M | · | $39M | $44M | $39M | · | $58M | $48M | $40M | · | $32M | $9M | $8M | · | $9M | |
| Net Income TTM | $-26M | $-30M | · | $-40M | $-51M | $-62M | · | $-51M | $-46M | $-41M | · | $-40M | $-66M | $-86M | · | $-96M | |
| Market Cap | $129M | $135M | · | $106M | $163M | $40M | · | $73M | $70M | $93M | · | $64M | $76M | $76M | · | $86M | |
| P/E | -4.9 | -4.3 | · | -2.6 | -3.1 | -0.6 | · | -1.4 | -1.5 | -2.2 | · | -1.4 | -0.9 | -0.6 | · | -0.7 | |
| P/S | 6.5 | 5.3 | · | 2.7 | 3.7 | 1.0 | · | 1.2 | 1.5 | 2.3 | · | 2.0 | 8.7 | 9.4 | · | 9.4 | |
| P/B | 2.9 | 2.6 | · | 4.0 | 5.0 | 1.2 | · | 1.1 | 0.9 | 1.0 | · | 1.2 | 1.4 | 1.2 | · | 2.6 | |
| P / Tangible Book | 2.9 | 2.6 | · | 4.0 | 5.0 | 1.2 | · | 1.1 | 0.9 | 1.0 | · | 1.2 | 1.4 | 1.2 | · | 2.6 | |
| P / Cash Flow | · | 8.5 | · | · | · | -10.1 | · | · | · | 15.6 | · | · | · | -5.9 | · | · | |
| Earnings Yield | -20.4% | -23.1% | · | -38.8% | -32.1% | -158.3% | · | -70.9% | -66.1% | -45.4% | · | -71.9% | -115.9% | -169.7% | · | -145.5% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $67M | $48M | $104M | $54M | $18M |
| 영업이익률 % | 9.4% | -152.9% | 20.7% | -78.9% | -481.9% |
| 순이익 | $9M | $-69M | $23M | $-46M | $-90M |
| 희석 EPS | $0.15 | $-1.27 | $0.43 | $-1.23 | $-2.91 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 7.6 | 2.2 | 3.5 | 5.2 | 8.5 |
| 당좌 비율 | 4.5 | 1.1 | 2.1 | 5.0 | 7.8 |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 69개의 제출자 · $49.2M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 24 (+13 이전 분기 대비) | 11 (-1 이전 분기 대비) | 16 (+5 이전 분기 대비) | 8 (-3 이전 분기 대비) | +275K |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| GSK plc | $20,311,239 | 9,190,606 | 41.27% | 주식 |
| Pfizer Inc | $5,338,906 | 2,362,348 | 10.85% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $4,500,059 | 2,036,226 | 9.14% | 주식 |
| VANGUARD GROUP INC | $4,179,789 | 1,793,901 | 8.49% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $2,094,868 | 947,904 | 4.26% | 주식 |
| Alphabet Inc. | $1,966,854 | 889,979 | 4.00% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,678,031 | 759,290 | 3.41% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $1,026,816 | 464,370 | 2.09% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $846,019 | 382,814 | 1.72% | 주식 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $735,864 | 332,970 | 1.50% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $635,702 | 287,648 | 1.29% | 주식 |
| GOLDMAN SACHS GROUP INC | $567,937 | 256,985 | 1.15% | 주식 |
| TWO SIGMA ADVISERS, LP | $504,678 | 216,600 | 1.03% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $484,794 | 219,364 | 0.99% | 주식 |
| STATE STREET CORP | $474,600 | 214,751 | 0.96% | 주식 |
| JANE STREET GROUP, LLC | $349,394 | 158,097 | 0.71% | 주식 |
| UBS Group AG | $308,693 | 139,680 | 0.63% | 주식 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $253,708 | 114,800 | 0.52% | 주식 |
| NORTHERN TRUST CORP | $239,286 | 108,274 | 0.49% | 주식 |
| Point72 Asset Management, L.P. | $230,673 | 104,377 | 0.47% | 주식 |
| Ionic Capital Management LLC | $226,963 | 102,698 | 0.46% | 주식 |
| Federation des caisses Desjardins du Quebec | $202,180 | 91,900 | 0.41% | 주식 |
| Shay Capital LLC | $159,984 | 72,391 | 0.33% | 주식 |
| CITADEL ADVISORS LLC | $144,976 | 65,600 | 0.29% | 풋 옵션 |
| Invesco Ltd. | $141,981 | 64,245 | 0.29% | 주식 |
| SIMPLEX TRADING, LLC | $135,499 | 61,312 | 0.28% | 주식 |
| Verdad Advisers, LP | $113,450 | 51,335 | 0.23% | 주식 |
| XTX Topco Ltd | $111,685 | 50,536 | 0.23% | 주식 |
| JANE STREET GROUP, LLC | $104,091 | 47,100 | 0.21% | 콜 옵션 |
| AMERICAN CENTURY COMPANIES INC | $81,352 | 36,811 | 0.17% | 주식 |
| Cubist Systematic Strategies, LLC | $76,789 | 40,845 | 0.16% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $76,466 | 34,600 | 0.16% | 풋 옵션 |
| AXXCESS WEALTH MANAGEMENT, LLC | $71,931 | 32,548 | 0.15% | 주식 |
| Capital Asset Advisory Services LLC | $71,931 | 32,548 | 0.15% | 주식 |
| Three Seasons Wealth, LLC | $66,300 | 30,000 | 0.13% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $63,129 | 28,565 | 0.13% | 주식 |
| JANE STREET GROUP, LLC | $59,228 | 26,800 | 0.12% | 풋 옵션 |
| Vanguard Global Advisers, LLC | $56,236 | 25,446 | 0.11% | 주식 |
| Global Retirement Partners, LLC | $55,250 | 25,000 | 0.11% | 주식 |
| OPPENHEIMER & CO INC | $50,499 | 22,850 | 0.10% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $42,649 | 19,298 | 0.09% | 주식 |
| Assenagon Asset Management S.A. | $41,186 | 18,636 | 0.08% | 주식 |
| DLK Investment Management, LLC | $40,762 | 31,355 | 0.08% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $38,958 | 17,628 | 0.08% | 주식 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | $35,570 | 16,095 | 0.07% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $30,277 | 13,700 | 0.06% | 콜 옵션 |
| Qube Research & Technologies Ltd | $30,153 | 13,644 | 0.06% | 주식 |
| GROUP ONE TRADING LLC | $24,020 | 10,869 | 0.05% | 주식 |
| TWO SIGMA SECURITIES, LLC | $23,373 | 10,576 | 0.05% | 주식 |
| PRUDENTIAL FINANCIAL INC | $22,984 | 10,400 | 0.05% | 주식 |
| BlackRock, Inc. | $22,476 | 10,170 | 0.05% | 주식 |
| CITIGROUP INC | $21,271 | 9,625 | 0.04% | 주식 |
| JONES FINANCIAL COMPANIES LLLP | $17,352 | 7,678 | 0.04% | 주식 |
| Integrated Wealth Concepts LLC | $13,260 | 6,000 | 0.03% | 주식 |
| ROYAL BANK OF CANADA | $4,000 | 2,014 | 0.01% | 주식 |
| WR Wealth Planners, LLC | $2,678 | 2,600 | 0.01% | 주식 |
| RAYMOND JAMES FINANCIAL INC | $2,210 | 1,000 | 0.00% | 주식 |
| FMR LLC | $663 | 300 | 0.00% | 주식 |
| OSAIC HOLDINGS, INC. | $640 | 290 | 0.00% | 주식 |
| GSA CAPITAL PARTNERS LLP | $632 | 285,906 | 0.00% | 주식 |
| JPMORGAN CHASE & CO | $533 | 236 | 0.00% | 주식 |
| WELLS FARGO & COMPANY/MN | $442 | 200 | 0.00% | 주식 |
| Rialto Wealth Management, LLC | $381 | 172 | 0.00% | 주식 |
| US BANCORP \DE\ | $334 | 151 | 0.00% | 주식 |
| MORGAN STANLEY | $29 | 13 | 0.00% | 주식 |
| SBI Securities Co., Ltd. | $29 | 13 | 0.00% | 주식 |
| SG Americas Securities, LLC | $25 | 11,268 | 0.00% | 주식 |
| Farther Finance Advisors, LLC | $22 | 10 | 0.00% | 주식 |
| FNY Investment Advisers, LLC | $18 | 8,300 | 0.00% | 주식 |
회사 내부자 22 명의 내부자 · 9 임원 · 12 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Esther Rajavelu | Chief Executive Officer, Chief Financial Officer and Chief Business Officer | 2026년 5월 4일 S | 986,851 | 0 | 5 | $-406,848 |
| Sath Shukla | CEO & President | 2025년 2월 5일 S | 1,736,883 | 0 | 0 | $0 |
| Joel Sendek | Chief Financial Officer | 2019년 1월 2일 A | 15,181 | 0 | 0 | $0 |
| Timothy Keutzer | Chief Operating Officer | 2026년 2월 6일 S | 742,506 | 0 | 5 | $-148,532 |
| Cristina Larkin | Chief Operating Officer | 2022년 2월 1일 A | 63,581 | 0 | 0 | $0 |
| Kamal Hamed | Chief Medical Officer | 2024년 2월 2일 S | 788,117 | 0 | 0 | $0 |
| Tamara L Joseph | Chief Legal Officer | 2024년 2월 2일 S | 531,615 | 0 | 0 | $0 |
| David A. Melnick | Chief Medical Officer | 2022년 2월 1일 A | 62,081 | 0 | 0 | $0 |
| Thomas R Parr JR | Chief Scientific Officer | 2019년 1월 2일 A | — | 0 | 0 | $0 |
| Kathleen Tregoning | 이사 | 2026년 6월 23일 A | 85,000 | 0 | 0 | $0 |
| Cynthia Smith | 이사 | 2026년 6월 23일 A | 85,000 | 0 | 0 | $0 |
| Scott Thomas Jackson | 이사 | 2026년 6월 23일 A | 85,000 | 0 | 0 | $0 |
| Patrick V.J.J. Vink | 이사 | 2026년 6월 23일 A | 85,000 | 0 | 0 | $0 |
| Milind Deshpande | 이사 | 2026년 6월 23일 A | 101,454 | 0 | 0 | $0 |
| John C Pottage Jr | 이사 | 2026년 6월 23일 A | 85,000 | 0 | 0 | $0 |
| Frank E Thomas | 이사 | 2026년 6월 23일 A | 85,000 | 0 | 0 | $0 |
| Ankit Mahadevia | 이사 | 2025년 8월 28일 S | 703,294 | 0 | 1 | $-12,947 |
| FORMELA JEAN FRANCOIS | 이사 | 2021년 8월 17일 A | 2,408,128 | 0 | 0 | $0 |
| Casper Breum | 이사 | 2018년 6월 5일 A | 1,091,774 | 0 | 0 | $0 |
| David P Southwell | 이사 | 2018년 6월 5일 A | — | 0 | 0 | $0 |
| Vikas Goyal | 이사 | 2017년 11월 6일 C | 1,854,006 | 0 | 0 | $0 |
| Debra Zack | — | 2026년 8월 3일 A | 162,311 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 1 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| ATLAS VENTURE FUND X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC ×2 제출 서류 | 2021년 2월 16일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 8 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.21% | 39,513 SH | 2026년 8월 21일 | 일간 |
| IWC · iShares Trust | 0.01% | 153,193 SH | 2026년 8월 20일 | 일간 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.00% | 22,770 NS | 2026년 5월 31일 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.00% | 26,897 SH | 2026년 8월 21일 | 일간 |
| DFAS · Dimensional ETF Trust | 0.00% | 15,934 NS | 2026년 4월 30일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 593,254 SH | 2026년 8월 19일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,395,976 SH | 2026년 8월 19일 | 일간 |
| DFAC · Dimensional ETF Trust | 0.00% | 4,874 NS | 2026년 4월 30일 | N-PORT |